Last Updated on October 9, 2024 by The Health Master
The Indian Regulatory Authority, the Central Drug Standard Control Organization (CDSCO), which is part of the Health Ministry of India, has given the go-ahead for Xplore Health, a provider of medtech solutions, to market its medical watch CardiacSense.
The approval came ahead of its commercial launch in collaboration with Israeli Medtech company CardiacSense.
The product has already been approved by USFDA
The product has already been approved by USFDA. The CardiacSense will be accessible in Indian markets as well after receiving CDSCO approval.
The Indian regulatory authorities have given a green signal for its sale in India by issuing a registration certificate and license for its sales.
CardiacSense technology is intended to ensure that one’s vital signs are continuously monitored, and whenever the watch raises a notification for increased or decreased heart rates or arrhythmias, the watch prompts the user to take an ECG and immediately share it with the doctor for immediate advice.
It will enable doctors and hospitals to monitor patients 24/7.
It has features like live ECG monitoring and sophisticated vital sign monitoring systems, which will make patient monitoring for doctors and hospitals very efficient.
It can also monitor Atrial Fibrillation (AFib) 24/7 creating a record of Afib load with time logs of start and end of Afib events while patients wear the watch.
This helps doctors identify the risks to these patients and advise on treatments accordingly.
Having received approval from India, CardiacSense is now available in over 40 countries, including the USA, all European countries, Australia, New Zealand, and many other South American countries.
CDSCO panel gives nod for Icosapent Ethyl Capsules
CDSCO Panel nod for Cholecalciferol Aqueous Injection
CDCSO Panel gives nod to market for Ocrelizumab
CDSCO panel gives nod for BE study of Tadalafil Oral Jelly
CDSCO Panel gives nod Clinical Trial for this Anticancer Drug
CDSCO Panel gives nod for FDC Tamsulosin + Solifenacin
Arunachal Drug Department will soon get 8 more Drug Inspectors
USFDA gives approval for Saxagliptin Tablets 2.5 mg and 5 mg
NPPA proposes ceiling price of 26 more scheduled formulations
USFDA issues Form 483 with 8 observations to Cipla for Pithampur facility
Govt asks Pharma Industry to go for QR code instead of SMS Code
E-pharmacies under radar: Govt to initiate stern action
New guidelines for Blood Centres / Banks on bulk transfers: Maharashtra
FDA Haryana: Medical store sealed, drugs being sold at prices higher than MRP
Dissolution test: Importance in Pharma Industry
Latest Notifications regarding Pharmaceuticals
For informative videos on Medical Devices, click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
